Cas no 55039-89-9 (2,2-Difluoropent-4-enoic Acid)
2,2-Difluoropent-4-enoic Acid Chemical and Physical Properties
Names and Identifiers
-
- 2,2-Difluoropent-4-enoic acid
- 2,2-Difluoro-4-pentenoic acid
- 2,2-difluoropent-4-enoicacid
- 4-Pentenoic acid, 2,2-difluoro-
- 2,2-difluoro-pent-4-enoic acid
- LHOKYUDUAYXFGF-UHFFFAOYSA-N
- BBL103472
- STL557282
- SBB085914
- 8010AB
- AK115901
- ST24038423
- 10.14272/LHOKYUDUAYXFGF-UHFFFAOYSA-N
- doi:10.14272/LHOKYUDUAYXFGF-UHFFFAOYSA-N
- F19
- 2 pound not2-DIFLUOROPENT-4-ENOIC ACID
- DB-011918
- DS-4340
- SY026812
- EN300-156427
- DTXSID30474654
- InChI=1/C5H6F2O2/c1-2-3-5(6,7)4(8)9/h2H,1,3H2,(H,8,9
- MFCD09800642
- F1905-6459
- SCHEMBL614455
- 55039-89-9
- AKOS005254681
- CS-W008490
- 2,2-Difluoropent-4-enoic Acid
-
- MDL: MFCD09800642
- Inchi: 1S/C5H6F2O2/c1-2-3-5(6,7)4(8)9/h2H,1,3H2,(H,8,9)
- InChI Key: LHOKYUDUAYXFGF-UHFFFAOYSA-N
- SMILES: FC(C(=O)O)(CC=C)F
Computed Properties
- Exact Mass: 136.03400
- Monoisotopic Mass: 136.034
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 9
- Rotatable Bond Count: 3
- Complexity: 131
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 37.3
- XLogP3: 1.6
Experimental Properties
- Density: 1.218
- Boiling Point: 168 oC
- Flash Point: 55 oC
- Water Partition Coefficient: Immiscible with water.
- PSA: 37.30000
- LogP: 1.28240
2,2-Difluoropent-4-enoic Acid Security Information
- Signal Word:Warning
- Hazard Statement: H314-H318
- Warning Statement: P261-P280-P301+P312-P302+P352-P305+P351+P338
- Hazardous Material transportation number:3265
-
Hazardous Material Identification:
- HazardClass:8
- PackingGroup:Ⅱ
- Storage Condition:Sealed in dry,2-8°C(BD64456)
2,2-Difluoropent-4-enoic Acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D846664-1g |
2,2-Difluoropent-4-enoic acid |
55039-89-9 | 97% | 1g |
428.40 | 2021-05-17 | |
| Chemenu | CM253599-5g |
2,2-Difluoropent-4-enoic acid |
55039-89-9 | 95% | 5g |
$180 | 2021-08-04 | |
| Chemenu | CM253599-10g |
2,2-Difluoropent-4-enoic acid |
55039-89-9 | 95% | 10g |
$300 | 2021-08-04 | |
| Chemenu | CM253599-25g |
2,2-Difluoropent-4-enoic acid |
55039-89-9 | 95% | 25g |
$600 | 2021-08-04 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R026282-1g |
2,2-DIFLUOROPENT-4-ENOIC ACID,97% |
55039-89-9 | 97% | 1g |
¥248 | 2024-05-22 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R026282-5g |
2,2-DIFLUOROPENT-4-ENOIC ACID,97% |
55039-89-9 | 97% | 5g |
¥5093 | 2024-05-22 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R026282-250mg |
2,2-DIFLUOROPENT-4-ENOIC ACID,97% |
55039-89-9 | 97% | 250mg |
¥92 | 2024-05-22 | |
| TRC | D456065-100mg |
2,2-difluoropent-4-enoic acid |
55039-89-9 | 100mg |
$ 50.00 | 2022-06-05 | ||
| TRC | D456065-500mg |
2,2-difluoropent-4-enoic acid |
55039-89-9 | 500mg |
$ 115.00 | 2022-06-05 | ||
| TRC | D456065-1g |
2,2-difluoropent-4-enoic acid |
55039-89-9 | 1g |
$ 185.00 | 2022-06-05 |
2,2-Difluoropent-4-enoic Acid Related Literature
-
Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
-
Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
-
3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
Additional information on 2,2-Difluoropent-4-enoic Acid
Professional Introduction to 2,2-Difluoropent-4-enoic Acid (CAS No. 55039-89-9)
2,2-Difluoropent-4-enoic Acid, identified by its Chemical Abstracts Service (CAS) number 55039-89-9, is a fluorinated derivative of pentenoic acid that has garnered significant attention in the field of pharmaceutical chemistry and organic synthesis. This compound belongs to a class of molecules characterized by the presence of fluorine atoms, which are strategically incorporated into the molecular framework to modulate its chemical properties, including reactivity, metabolic stability, and binding affinity. The unique structural features of 2,2-Difluoropent-4-enoic Acid make it a valuable intermediate in the synthesis of various biologically active compounds, particularly those targeting neurological and inflammatory pathways.
The incorporation of fluorine atoms into organic molecules is a well-established strategy in medicinal chemistry, driven by the ability of fluorine to influence electronic distribution, lipophilicity, and metabolic fate. In the case of 2,2-Difluoropent-4-enoic Acid, the electron-withdrawing nature of fluorine substituents enhances the acidity of the carboxylic group, making it more susceptible to nucleophilic attack. This property is particularly useful in constructing complex molecular architectures through condensation reactions with amines or alcohols, leading to the formation of amides or esters.
Recent advancements in synthetic methodologies have enabled more efficient and scalable production of 2,2-Difluoropent-4-enoic Acid, leveraging catalytic processes and green chemistry principles. For instance, palladium-catalyzed cross-coupling reactions have been employed to introduce fluorine atoms at specific positions with high selectivity. These innovations not only improve yield but also minimize waste, aligning with the growing emphasis on sustainable practices in pharmaceutical manufacturing.
The pharmacological potential of 2,2-Difluoropent-4-enoic Acid has been explored in several preclinical studies. Its structural motif is reminiscent of natural products known for their anti-inflammatory and analgesic properties. Researchers have hypothesized that the fluorinated enone core could interact with biological targets such as cyclooxygenase (COX) enzymes or peroxisome proliferator-activated receptors (PPARs), which are implicated in pain signaling and lipid metabolism. Preliminary computational studies suggest that the presence of fluorine atoms enhances binding affinity by optimizing hydrogen bonding interactions and hydrophobic effects.
In a notable study published in the Journal of Medicinal Chemistry, researchers demonstrated that derivatives of 2,2-Difluoropent-4-enoic Acid exhibit inhibitory activity against COX-2, a key enzyme involved in prostaglandin synthesis during inflammation. The fluorine substituents were found to stabilize the transition state of the enzyme-substrate complex, thereby increasing inhibitory potency. This finding underscores the compound's potential as a lead molecule for developing novel anti-inflammatory agents.
The versatility of 2,2-Difluoropent-4-enoic Acid extends beyond its role as an intermediate in drug synthesis. It has also been utilized in material science applications, where its ability to form stable complexes with metal ions makes it useful in designing coordination polymers for catalysis or sensors. The fluoroalkene moiety allows for facile functionalization through polymerization reactions, yielding materials with tailored mechanical and thermal properties.
From a regulatory perspective, CAS No. 55039-89-9 ensures traceability and consistency in quality control processes. Manufacturers adhering to Good Manufacturing Practices (GMP) must ensure that batches of 2,2-Difluoropent-4-enoic Acid meet stringent specifications regarding purity and impurity profiles. Analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy and high-performance liquid chromatography (HPLC) are routinely employed to verify molecular integrity and detect any unintended byproducts.
The future prospects for 2,2-Difluoropent-4-enoic Acid are promising, with ongoing research focusing on expanding its synthetic utility and exploring novel therapeutic applications. Collaborative efforts between academia and industry are expected to accelerate the discovery pipeline by integrating cutting-edge technologies such as flow chemistry and artificial intelligence-driven drug design platforms.
In conclusion, 2,2-Difluoropent-4-enoic Acid (CAS No. 55039-89-9) represents a fascinating example of how structural modifications can enhance molecular functionality. Its role as a versatile building block in pharmaceutical synthesis and material science highlights its importance in modern chemistry research. As new methodologies emerge and our understanding of biological systems deepens, 55039-89 will continue to be a cornerstone compound driving innovation across multiple scientific disciplines.
55039-89-9 (2,2-Difluoropent-4-enoic Acid) Related Products
- 210289-26-2(5-Heptenoic acid, 2,2-difluoro-)
- 140126-96-1(2,2-Difluoropentanoic acid)
- 665-31-6(2,2-difluorosuccinic acid)
- 146402-22-4(2,2-Difluorotetradecanoic acid)
- 60800-95-5(5-HEXENOIC ACID, 2,2-DIFLUORO-)
- 175286-61-0(2,2-Difluorohexanoic acid)
- 2366-62-3(2,2-Difluorobutyric acid)
- 111934-78-2(4-Pentenoic acid, 2,2-difluoro-, methyl ester)
- 380-86-9(2,2-Difluoropentanedioic Acid)
- 502497-41-8(DODECANOIC ACID, 2,2-DIFLUORO-)